about
Macrogenics Inc is a biotechnology company focused on discovering and developing antibody-based therapeutics for the treatment of cancer. Its product includes MARGENZA, which is for the treatment of adult patients with metastatic HER2-positive breast...
Read More
2.02
0.31
(18.13%)
3.4M
XNAS Volume
High volume+gain today
XNAS 21 Oct, 2025 5:30 PM (EDT)
Low Financial Strength
Expensive Valuation
Technically Moderately Bullish
Momentum Trap
These stocks are with a bad quality and poor financial score ranging from medium to expensive valuation. Rising technical aspects may attract investors, but, weak financials cannot be overlooked.
View Similar
Embed DVM
Macrogenics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..